Implementation of a dual platelet inventory in a tertiary hospital during the COVID‐19 pandemic enabling cold‐stored apheresis platelets for treatment of actively bleeding patients

CSP with 14-days shelf life is a feasible alternative for the treatment of patients with bleeding. Implementation of a dual platelet inventory requires thorough planning, including information and training of clinical and laboratory staff, continuous follow-up of practice and patients, and an easy-to-follow algorithm for use of CSP units. A dual platelet inventory may mitigate the risk of platelet shortage during a pandemic situation.